Background: Pediatric cancer patients are considered one of vulnerable group for Covid-19 infections and its associated complication. We assessed prevalence implications in pediatric NorthEast India. Methods: Retrospective study was conducted between July 2020 to June 2021 at Dr B Borooah Cancer Institute (BBCI), Guwahati, Assam, Medical records the childhood were analyzed. All who tested SARS-...

Introduction: Previous reviews of phase 1 trials in oncology have reported a treatment response rate 4%–6% and toxicity-related mortality 0.5%. These results may not reflect current Phase trial rates for patients with lymphoma. Methods: All non-pediatric relapsed or refractory (R/R) lymphoma approved by the Cancer Therapy Evaluation Program Institut Gustave Roussy between 2008 2023 (cut-off dat...

calcium metabolic disorders, such as hypercalcemia is a potentially life-threatening disorder especially when coupled with an already compromised condition. the aim of this study was to determine the prevalence of metabolic calcium disorders in childhood cancers of patients admitted to the pediatric ward of vali-asr hospital from the year 2001-2008. the study was carried out by reviewing hospit...

The Epstein-Barr virus (EBV) is strongly associated with endemic Burkitt lymphoma (BL) and can also be found in a subset of other non-Hodgkin lymphomas (NHLs).1 At the present time, only very limited information is available regarding the prevalence of EBV in pediatric NHL in Western Europe and the United States. Concurrently, little data exists in regard to EBV gene expression patterns in pedi...

Background: Fever and neutropenia (FN) is a common complication of pediatric cancer treatment, but hospital utilization patterns for this condition are not well described. Methods: Data were analyzed from the Kids’ Inpatient Database (KID), an all-payer US hospital database, for 2009. Pediatric FN patients were identified using: age ≤19 years, urgent or emergent admit type, non-transferred, and...